
Thoratec scooped up by St. Jude for $3.5bn
Executive Summary
St. Jude Medical Inc. paid $3.5bn or $63.50 per share (a 34% premium) for fellow public cardiovascular-focused device firm Thoratec Corp.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com